SCYNEXIS
SCYX
$2.42
Share price
2.77%
Change (1 day)
-7.82%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Net assets
Net assets on the balance sheet as of March 2024 : $74.1 M
According to SCYNEXIS's latest financial reports the company has $74.1 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
SCYNEXIS - Net assets on balance sheet (from 2013 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $3.23 M | -92.16% |
| 2021-12-31 | $41.25 M | 81.29% |
| 2020-12-31 | $22.75 M | 76.49% |
| 2019-12-31 | $12.89 M | -58.7% |
| 2018-12-31 | $31.22 M | 45.84% |
| 2017-12-31 | $21.41 M | -38.51% |
| 2016-12-31 | $34.81 M | -17% |
| 2015-12-31 | $41.94 M | 25.48% |
| 2014-12-31 | $33.43 M | -259.56% |
| 2013-12-31 | $-20.96 M | 8.4% |
| 2012-12-31 | $-19.33 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $13.87 M | -81.27% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $0.56 B | 657.59% | 🇺🇸 USA |
 Catalent CTLT | $3.61 B | 4,772.82% | 🇺🇸 USA |
 KemPharm KMPH | $85.8 M | 15.79% | 🇺🇸 USA |